Literature DB >> 21236414

The maximal tolerable reduction in hyperopic correction in patients with refractive accommodative esotropia: a 6-month follow-up study.

Kyung-Ah Park1, Sung Min Kim, Sei Yeul Oh.   

Abstract

PURPOSE: To investigate the optimal amount of safe under-correction in patients with refractive accommodative esotropia.
DESIGN: Prospective noncomparative interventional case series.
METHODS: Patients with refractive accommodative esotropia wore trial glasses based on cycloplegic refraction, then -0.25 diopters (D) of minus sphere lenses were placed on both lenses of the trial glasses and the deviation was measured. Minus spheres of -0.25 D were continuously added until the angle of deviation increased; the minus spheres added just before the deviation increase were defined as the maximal tolerable amount of under-correction. A total of 38 patients were prescribed under-corrected spectacles up to -1.5 D and followed for 6 months.
RESULTS: Thirty-one patients underwent the maximal tolerable amount of under-correction and 7 underwent -1.5 D of under-correction. A mean -0.89 D of under-correction was performed. We observed no deterioration in visual acuity, stereoacuity, or fusional ability during the follow-up period in any of the patients. Small increase in the angle of deviation of 2 prism diopters was noted in 2 patients. The mean spherical equivalent refractive error of both eyes (P = .012) and age of onset (P = .006) showed strong positive correlations with the maximal tolerable amount of under-correction.
CONCLUSIONS: A reduction in hyperopic correction by the maximal tolerable amount of under-correction was performed without notable short-term side effects. The spherical equivalent refractive error and age of onset appear to be useful clinical indices in determining the appropriate amount of under-correction.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21236414     DOI: 10.1016/j.ajo.2010.09.023

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Prognostic factors for stereopsis in refractive accommodative esotropia.

Authors:  Hande Guclu; Vuslat Pelitli Gurlu; Sadik Altan Ozal; Zeynep Gursel Ozkurt
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

2.  Validation of an Independent Web-Based Tool for Measuring Visual Acuity and Refractive Error (the Manifest versus Online Refractive Evaluation Trial): Prospective Open-Label Noninferiority Clinical Trial.

Authors:  Robert P L Wisse; Marc B Muijzer; Francesco Cassano; Daniel A Godefrooij; Yves F D M Prevoo; Nienke Soeters
Journal:  J Med Internet Res       Date:  2019-11-08       Impact factor: 5.428

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.